RasGTPase-activating protein is a target of caspases in spontaneous apoptosis of lung carcinoma cells and in response to etoposide

Carcinogenesis

Volumn 25, Issue 6, 2004, Pages 909-921

  Bartling, Babett ^a   Yang, Jiang Yan ^b   Michod, David ^b   Widmann, Christian ^b   Lewensohn, Rolf ^a   Zhivotovsky, Boris ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 3; CASPASE INHIBITOR; DNA; ETOPOSIDE; FAS ANTIBODY; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MONOCLONAL ANTIBODY; STAUROSPORINE; SY 001; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER THERAPY; CARCINOMA CELL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE COURSE; DRUG RESISTANCE; DRUG RESPONSE; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR CELL LINE; ENZYME ACTIVATION; ENZYMOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; SMALL CELL CARCINOMA;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CASPASES; CELL LINE, TUMOR; ENZYME ACTIVATION; ETOPOSIDE; HUMANS; LUNG NEOPLASMS; RAS GTPASE-ACTIVATING PROTEINS;

EID: 3042733029     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh075     Document Type: Article

References (44)

1. Geenlee,R., Hill-Harmon,M., Murray,T. and Thun,M. (2001) Cancer statistics, 2001. CA Cancer J. Clin., 51, 15-36.
2. Li,T.K. and Liu,L.F. (2001) Tumor cell death induced by topoisomerase-targeting drugs. Annu. Rev. Pharmacol. Toxicol., 41, 53-77.
3. Ferraro,C., Quemeneur,L., Fournel,S., Prigent,A.F., Revillard,J.P. and Bonnefoy-Berard,N. (2000) The topoisomerase inhibitors camptothecin and etoposide induce a CD95- independent apoptosis of activated peripheral lymphocytes. Cell Death Differ., 7, 197-206.
4. Thornberry,N.A. and Lazebnik,Y. (1998) Caspases: enemies within. Science, 281, 1312-1316.
5. Hengartner,M.O. (2000) The biochemistry of apoptosis. Nature, 407, 770-776.
6. Earnshaw,W., Martins,L. and Kaufmann,S. (1999) Mammalian caspases: structure, activation, substrates and functions during apoptosis. Annu. Rev. Biochem., 68, 383-424.
7. Donovan,S., Shannon,K.M. and Bollag,G. (2002) GTPase activating proteins: critical regulators of intracellular signaling. Biochim. Biophys. Acta, 1602, 23-45.
8. Yang,J.Y. and Widmann,C. (2001) Antiapoptotic signaling generated by caspase-induced cleavage of RasGAP. Mol. Cell. Biol., 21, 5346-5358.
9. Pomerance,M., Thang,N., Tocque,B. and Pierre,M. (1996) The RasGTPase-activating protein SH3 domain is required for Cdc2 activation and mos induction by oncogenic Ras in Xenopus oocytes independently of mitogen-activated protein kinase activation. Mol. Biol. Cell, 16, 3179-3186.
10. Yang,J.Y. and Widmann,C. (2002) The RasGAP N-terminal fragment generated by caspase cleavage protects cells in a Ras/PI3K/Akt-dependent manner that does not rely on NFkappa B activation. J. Biol. Chem., 277, 14641-14646.
11. Vanhaesebroeck,B. and Alessi,D. (2000) The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J., 346, 561-576.
12. Datta,S.R., Dudek,H., Tao,X., Masters,S., Fu,H., Gotoh,Y. and Greenberg,M.E. (1997) Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-241.
13. Tsuruta,F., Masuyama,N. and Gotoh,Y. (2002) The phosphatidylinositol 3-kinase (PIP3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem., 277, 14040-14047.
14. Cardone,M.H., Roy,N., Stennicke,H.R., Salvesen,G.S., Franke,T.F., Stanbridge,E., Frisch,S. and Reed,J.C. (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science, 282, 1318-1321.
15. Romashkova,J. and Makarov,S. (1999) NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature, 401, 86-90.
16. Travis,W., Colby,R., Corrin,B., Shimosato,Y., Brambilla,E., in collaboration with Sobin,L.H. and pathologists from 14 countries (1999) WHO International Classification of Tumours. Histological Typing of Lung and Pleural Tumours. Springer, Berlin.
17. Sekido,Y., Fong,K. and Minna,J. (1998) Progress in understanding the molecular pathogenesis of human lung cancer. Biochim. Biophys. Acta, 1378, F21-F59.
18. Comis,R., Friedland,D. and Good,B. (1998) Small-cell lung cancer: a perspective on the past and a preview of the future. Oncology, 12, 44-50.
19. Beck,W.T., Morgan,S.E., Mo,Y.Y. and Bhat,U.G. (1999) Tumor cell resistance to DNA topoisomerase II inhibitors: new developments. Drug Resist. Updat., 2, 382-389.
20. Joseph,B., Lewensohn,R. and Zhivotovsky,B. (2000) Role of apoptosis in the response of lung carcinomas to anti-cancer treatment. Ann. N. Y. Acad. Sci., 926, 204-216.
21. Joseph,B., Ekedahl,J., Lewensohn,R., Marchetti,P., Formstecher,P. and Zhivotovsky,B. (2001) Defective caspase-3 relocalization in non-small cell lung carcinoma. Oncogene, 20, 2877-2888.
22. Brognard,J., Clark,A., Ni,Y. and Dennis,P. (2001) Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res., 61, 3986-3997.
23. Krystal,G., Sulanke,G. and Litz,J. (2002) Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis and enhances sensitivity of small cell lung cancer cells to chemotherapy. Mol. Cancer Ther., 1, 913-922.
24. Friedman,E. (1995) The role of ras GTPase activating protein in human tumorigenesis. Pathobiology, 63, 348-350.
25. Ekedahl,J., Joseph,B., Grigoriev,M.Y., Muller,M., Magnusson,C., Lewensohn,R. and Zhivotovsky,B. (2002) Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells. Exp. Cell Res., 279, 277-290.
26. Joseph,B., Marchetti,P., Formstecher,P., Kroemer,G., Lewensohn,R. and Zhivotovsky,B. (2002) Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene, 21, 65-77.
27. Susin,S.A., Daugas,E., Ravagnan,L. et al. (2000) Two distinct pathways leading to nuclear apoptosis. J. Exp. Med., 192, 571-580.
28. Heenan,M., Kavanagh,K., Redmond,A., Maher,M., Dolan,E., O'Neill,P., Moriarty,M. and Clynes,M. (1996) Absence of correlation between chemo- and radioresistance in a range of human tumour cell lines. Cytotechnology, 19, 237-242.
29. Iyengar,P. and Tsao,M.-S. (2002) Clinical relevance of molecular markers in lung cancer. Surg. Oncol., 11, 167-179.
30. Scheffzek,K., Lautwein,A., Scherer,A., Franken,S. and Wittinghofer,A. (1997) Crystallization and preliminary X-ray crystallographic study of the Ras-GTPase-activating domain of human p120GAP. Proteins, 27, 315-318.
31. Davidson,B., Agulansky,L., Goldberg,I., Friedman,E., Ramon,J., Barshack,I. and Kopolovic,J. (1998) Immunhistochemical analysis of rasGTPase activating protein (rasGAP) in prostate cancer. Pathol. Res. Pract., 194, 399-404.
32. Stahle-Backdhal,M., Inoue,M., Zedenius,J., Sandstedt,B., DeMarco,L., Flam,F., Silfversward,C., Andrade,J. and Friedman,E. (1995) Decreased expression of Ras GTPase activating protein in human trophoblastic tumors. Am. J. Pathol., 146, 1073-1078.
33. Barshack,I., Goldberg,I., Davidson,B., Ravid,A., Schiby,G., Kopolovic,J., Leviav,A. and Friedman,E. (1998) Expression of rasGTPase activating protein in basal cell carcinoma of the skin. Mod. Pathol., 11, 271-275.
34. Leblanc,V., Delumeau,I. and Tocque,B. (1999) Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells. Oncogene, 18, 4884-4889.
35. Sirzen,F., Zhivotovsky,B., Nilsson,A., Bergh,J. and Lewensohn,R. (1998) Higher spontaneous apoptotic index in small cell compared with non-small cell lung carcinoma cell lines; lack of correlation with Bc1- 2/Bax. Lung Cancer, 22, 1-13.
36. Henkemeyer,M., Rossi,D., Holmyard,D., Puri,M., Mbamalu,G., Harpal,K., Shih,T., Jacks,T. and Pawson,T. (1995) Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. Nature, 377, 695-701.
37. Scheffzek,K., Ahmadian,M., Kabsch,W., Wiesmueller,L., Lautwein,A., Schmitz,F. and Wittinghofer,A. (1997) The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science, 277, 333-338.
38. Leblanc,V., Tocque,B. and Delumeau,I. (1998) Ras-GAP controls Rho-mediated cytoskeletal reorganization through its SH3 domain. Mol. Cell. Biol., 18, 5567-5578.
39. Kraus,A., Ferber,I., Bachmann,S., Specht,H., Wimmel,A., Gross,M., Schlegel,J., Suske,G. and Schuermann,M. (2002) In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene, 21, 8683-8695.
40. Lee,S., Kim,H., Park,W., Kim,S., Lee,K., Kim,S., Lee,J. and Yoo,N. (2002) Non-small cell lung cancers frequently express phosphorylated Akt; an immunohistochemical study. Acta Pathol. Microbiol. Immunol. Scand., 110, 587-592.
41. Tang,D., Okada,H., Ruland,J., Liu,L., Stambolic,V., Mak,T. and Ingram,A. (2001) Akt is activated in response to an apoptotic signal. J. Biol. Chem., 276, 30461-30466.
42. Hill,M., Andjelkovic,M., Brazil,D., Ferrari,S., Fabbro,D. and Hemmings,B. (2001) Insulin-stimulated protein kinase B phosphorylation on Ser-473 is independent of its activity and occurs through a staurosporine-insensitive kinase. J. Biol. Chem., 276, 25643-25646.
43. Widmann,C., Gibson,S. and Johnson,G. (1998) Caspase-dependent cleavage of signaling proteins during apoptosis. A turn-off mechanism for anti-apoptotic signals. J. Biol. Chem., 273, 7141-7147.
44. Joseph,B., Ekedahl,J., Sirzen,F., Lewensohn,R. and Zhivotovsky,B. (1999) Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma. Biochem. Biophys. Res. Commun., 262, 381-387.